Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery

Circulation Research

Volumn 80, Issue 3, 1997, Pages 327-335

  Chen, Alex F Y ^b   O'Brien, Timothy ^b   Tsutsui, Masato ^b   Kinoshita, Hiroyuki ^b   Pompili, Vincent J ^b   Crotty, Thomas B ^b   Spector, David J ^b   Katusic, Zvonimir S ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

adenovirus vector; cerebral artery; gene therapy; nitric oxide synthase

Indexed keywords

BETA GALACTOSIDASE; CALCIMYCIN; CYCLIC GMP; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; URIDINE TRIPHOSPHATE;

ADENOVIRUS; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; BLOOD VESSEL WALL; DOG; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

EID: 0031059375     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.3.327     Document Type: Article

References (46)

1. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175-195.
2. Katusic ZS, Cosentino F. Nitric oxide synthase: from molecular biology to cerebrovascular physiology. News Physiol Sci. 1994;9:64-67.
3. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
4. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994;14:175-192.
5. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 1995;91:139-144.
6. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke. 1993;24:392-399.
7. Chen FY, Lee TJ-F. Arginine synthesis from citrulline in perivascular nerves of cerebral artery. J Pharmacol Exp Ther. 1995;273:895-901.
8. Chen FY, Lee TJ-F. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery. J Pharmacol Exp Ther. 1993;265:339-345.
9. Nabel EG, Nabel GJ. Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol. 1994;56:741-761.
10. Schneider MD, French BA. The advent of adenovirus: gene therapy for cardiovascular disease. Circulation. 1993;88:1937-1942.
11. Schulick AH, Dong G, Newman KD, Virmani R, Dichek DA. Endothelium-specific in vivo gene transfer. Circ Res. 1995;77:475-485.
12. Schulick AH, Newman KD, Virmani R, Dichek DA. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation. 1995;91:2407-2414.
13. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73:797-807.
14. Rios CD, Ooboshi H, Piegors D, Davidson BL, Hetstad DD. Adenovirus-mediated gene transfer to normal and atherosclerotic arteries: a novel approach. Arterioscler Thromb Vasc Biol. 1995;15:2241-2245.
15. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res. 1995;77:7-13.
16. Simmons M, Edelman ER, Dekeyser J-L, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 1992;359:67-70.
17. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
18. Janssens SP, Bloch KD, Nong Z, Gerard RD, Zoldhelyi P, Collen D. Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest. 1996;98:317-324.
19. Tzeng E, Shears LL II, Robbins PD, Pitt BR, Geller DA, Watkins SC, Simmons RL, Billiar TR. Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia. Mol Med. 1996;2:211-225.
20. Spector DJ, Samaniego LA. Construction and isolation of recombinant adenovirus with gene replacements. Methods Mol Genet. 1995;7:31-44.
21. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by human adenovirus type 5. J Gen Virol. 1977;36:59-74.
22. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 1979;17:683-689.
23. Volkert FC, Young CS. The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. Virology. 1983;125:175-193.
24. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A. 1991;88:2811-2814.
25. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A. 1991;88:7797-7801.
26. Sanes JR, Rubenstein JLR, Nicolas JF. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 1986;5:3133-3142.
27. G-monomethyl-L-arginine in canine basilar artery. Stroke. 1991;22:1399-1404.
28. Goetz U, Da Prada M, Pletscher A. Adenine-, guanine- and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther. 1971;178:210-215.
29. Urquilla PR, Van Dyke K, Trush M. Structure-activity relation of pyrimidine nucleotides and nucleoside in canine isolated cerebral vessels. J Pharm Pharmacol. 1978;30:189-190.
30. Urquilla PR. Prolonged contraction of isolated human and canine cerebral arteries induced by uridine 5′-triphosphate. Stroke. 1978;9:133-136.
31. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319-1330.
32. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 1995;96:2955-2965.
33. Annex BH, Davies, MG, Channon KM, Blazing MA, Taylor DA, George SE, Denning SM, Hagen P-O, Peters KG. Alteration of rabbit carotid artery vasomotor function by gene transfer with a replication deficient adenovirus. J Am Coll Cordiol. 1995:25(spedal issue): 366A. Abstract.
34. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol. 1991;41:485-490.
35. McDonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med. 1996;211:1-6.
36. Vallance P, Leone A, Culver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
37. Cosentino F, Sill JC, Katusic ZS. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. Am J Physiol. 1993;264:H413-H418.
38. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
39. Kim P, Sundt TM Jr, Vanhoutte PM. Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg. 1988;69:239-246.
40. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res. 1992;70:248-256.
41. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg. 1996;84:648-654.
42. Frazee JG, Giannotta SL, Stern WE. Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg. 1981;55:865-868.
43. Afshar JKB, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg, 1995;83:118-122.
44. Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage. J Neurosurg. 1994;80:476-483.
45. Toole JF. Subarachnoid hemorrhage, In: Toole JF, ed. Cerebrovascular Disorders. New York, NY: Raven Press Publishers; 1990:451-469.
46. Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-548.